Transaction · 0001628280-26-065566

RIKER LAUREN

RIKER LAUREN, SVP, reported an open-market or private sale at Pacira BioSciences, Inc. involving 6000.000000 shares for an estimated $217920.00. Reported holdings after the transaction were 62284.242000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSVP
PCRXPacira BioSciences, Inc.
Filing timeOct 09
Trade dateOct 08, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded8.79%Shares sold ÷ (holdings after + shares sold). Estimated position before: 68,284.242 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$24.48
Pre-filing
1mo ago +5.7%1w ago +0.0%1d ago +0.0%
Returns since
7d30d90d180d1y

PCRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PCRX since 2026-10-09Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-26-065566
Common Stock
Transaction date
Oct 08, 2026
Filed Oct 09, 2026, 11:07 PM · 1d delay
Shares
6.00k sh
$36.32 per share
Estimated value
-$217k
Computed from shares × price
Holdings after
62.2k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Senior Vice President, Finance

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exc…

  2. F2

    The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installmen…

Original filing · 0001628280-26-065566
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PCRX